AUSTIN, Texas--(BUSINESS WIRE)--Clinical laboratories and anatomic pathology groups throughout the U.S. continue to fight to obtain adequate COVID-19 tests and collection kits, even as payers deny many legitimate testing claims. To help labs with both issues, the Virtual 2020 Executive War College on Laboratory Management kicked off Tuesday, August 4.
The clinical lab industry’s most important management meeting of the year, this is the first national conference to bring together almost 500 senior lab executives, lab administrators, pathologists, consultants, and IVD managers to share solutions and exchange knowledge about vendors able to deliver collection supplies, viral transport media, lab analyzers, COVID-19 tests, and reagents. Lab billing and collections experts will discuss why payers are denying COVID-19 and other test claims while sharing steps to take to get both COVID-19 and routine test claims paid.
Because lab professionals are working long hours to respond to the demand for COVID-19 testing, Virtual 2020 Executive War College will present one 60-minute general session and one 60-minute management master class each week for the next 12 weeks. Specialized topic sessions will also be provided to attendees. Live presentations allow participants to interact with speakers, with all sessions available to view on-demand, 24/7. Among the opening presentations:
-
Thursday, August 6, 1 PM - 2PM EDT
Today’s Lab and Diagnostics Marketplace: Understanding the Reality and the Strategic Imperatives for All Labs and Diagnostic Companies: Lâle White, Chair/CEO, XIFIN
-
Tuesday, August 11, 1 PM – 2 PM EDT
Anatomic Pathology During the Pandemic: Two Pathology Super Groups Share Their Setbacks, Strategies, Solutions, and Successes: Cory Roberts, President/CEO, ProPath and Patty Sipes, CEO, Incyte Diagnostics
Conference participants have the opportunity to network at virtual receptions, meet major vendors of COVID-19 instruments, tests, and supplies, and work with billing and collections consultants to enhance lab revenue.
“This is a prime opportunity to interact with, and learn from lab peers proven ways to deal with COVID-19 and get paid for lab tests and services,” stated Robert Michel. “The still-increasing demand for COVID-19 tests means that clinical labs can expect to be paid adequate reimbursement for these huge numbers of antibody tests. That added cash flow is badly needed at the moment and will help keep many labs financially solvent.”
For details on speakers and sessions and to register, visit https://www.executivewarcollege.com.
